peptide elongation factor 2 has been researched along with dorsomorphin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Klann, E; Ma, T; Marambaud, P; Vingtdeux, V; Viollet, B; Zhao, H | 1 |
1 other study(ies) available for peptide elongation factor 2 and dorsomorphin
Article | Year |
---|---|
Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; AMP-Activated Protein Kinases; Amyloid beta-Protein Precursor; Animals; Cells, Cultured; Elongation Factor 2 Kinase; Excitatory Postsynaptic Potentials; Female; Hippocampus; Humans; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Mice; Mice, Inbred C57BL; Peptide Elongation Factor 2; Presenilin-1; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Signal Transduction | 2014 |